Navigation Links
BMP Sunstone Reports First Quarter 2008 Financial Results
Date:5/19/2008

- Company Reports Record Revenue and Gross Margin Performance -

- Revenue Increased 218% Year Over Year to $18.1 million -

- 42.7% Gross Margin Reached in 1Q 2008 -

PLYMOUTH MEETING, Penn., May 19 /Xinhua-PRNewswire-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company"), today announced its financial results from the first quarter of 2008. The Company intends to file its Form 10Q today.

Key Highlights from the First Quarter of 2008 include:

-- Revenue increased 218% year over year to $18.1 million from $5.7

million in 1Q07

-- Gross profit increased to $7.7 million from $654,000 in 1Q07

-- Gross margin increased to 42.7% from 11.5% in 1Q07

-- Adjusted EBITDA improves to $1,523,000 from a loss of $1.4 million in

1Q07

David Gao, Chief Executive Officer of BMP Sunstone, stated, "Our first quarter 2008 financial results are the strongest achieved in our Company's history and reflect the initial revenue and gross margin contributions from Sunstone. Our growing licensed products business also drove gross margin improvements and we are excited about the increasing presence we are realizing at BMP China."

Gao continued, "Through the Sunstone acquisition, we significantly enhanced our product offering with two of China's leading healthcare brands in therapeutic areas that we believe are extremely compelling: pediatrics and women's health. We also expanded our distribution reach into more than 50,000 retail pharmacies in China. With a stronger brand portfolio and a materially larger retail presence, we remain dedicated to realizing synergies across our organization in 2008 and beyond."

Revenue for the fi
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. BMP Sunstone Donates RMB 1.2 Million to Earthquake Relief
2. BMP Sunstone Announces Participation in May Investor Conferences
3. BMP Sunstone to Report First Quarter 2008 Financial Results
4. BMP Sunstones Propess(R) Recommended as First Line Treatment By the Chinese Medical Association
5. Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008
6. CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
7. Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008
8. China Yingxia International, Inc. Reports First Quarter 2008 Results
9. Digital Power Reports Financial Results for the First Quarter Ended March 31, 2008
10. Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008
11. Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... Northwestern Medicine scientists could lead to potential new treatments ... with scleroderma. , Fibrosis, or scarring, is a ... skin and lungs can lead to serious organ damage ... new therapeutic options centers on findings made by Swati ... the role that a specific protein plays in promoting ...
(Date:4/17/2014)... Ill. One of the most popular vaccine brands ... And doctors may be overlooking some cost factors when ... a more expensive option, according to a new study ... vaccines to administer can be driven by numerous factors," ... and a professor of computer science and of mathematics ...
(Date:4/17/2014)... a review published in the April issue of ... Feinstein Institute for Medical Research, says it,s time to ... approach to treating sepsis, which kills millions worldwide ... occurs when molecules released into the bloodstream to fight ... Inflammation is necessary for maintaining good health without ...
(Date:4/17/2014)... as 10 million older Americans suffer from depression, often ... However, new research a project that followed the ... years found that Internet use among the elderly ... 30 percent. , "That,s a very strong effect," said ... information studies and media who led the project. "And ...
(Date:4/17/2014)... YORK April 17, 2014 EcoHealth Alliance, a ... health issues, published a comprehensive review today examining the ... Marburg virus. The review calls for improved global surveillance ... as the recent outbreak of Ebola in West Africa ... the countries of Guinea and Liberia. According to ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Internet use can help ward off depression among elderly 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3
... Current ,safe, levels of exposure set by CDC need to ... -- Children with blood lead levels well below those considered ... emotional development, British researchers report. , Currently, the maximum safe ... mcg/dl), which was set by the U.S. Centers for Disease ...
... ... professor at the University of Colorado Denver and Health Sciences Center, School of Business, ... healthcare communications company. , ... Knoxville, Tenn. (PRWEB) September 17, 2009 -- Michael Guthrie, MD, MBA, Executive in ...
... ... advisory board for PerfectServe, a healthcare communications company. , ... Knoxville, TN (PRWeb) Sept. 17, 2009 -- Alan ... company. The board provides guidance on innovative ways to leverage PerfectServe,s physician-contact network serving ...
... , , , ... with prescription drug coverage are more satisfied with their pharmacy ... those with wholly private insurance, according to the J.D. Power ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20050527/LAF028LOGO-a ) , , ...
... , PITTSBURGH, Sept. 17 ... solutions for individuals with speech, language and learning disabilities, today ... the Year award from Microsoft Corp. This award recognizes ... Microsoft software in their products. , , ...
... 17 Racial inequalities in health care access and quality ... health care costs over a four-year period according to a ... Economic Studies, a Washington-based think tank. , , ... University of Maryland found that over 30 percent of direct ...
Cached Medicine News:Health News:Even Small Amounts of Lead Harmful to Kids 2Health News:Even Small Amounts of Lead Harmful to Kids 3Health News:Dr. Michael Guthrie Named to PerfectServe Advisory Board 2Health News:Alan Weinstein Named Chairman of PerfectServe Advisory Board 2Health News:J.D. Power and Associates Reports: Among Pharmacy Customers, Satisfaction is Equally as High for the Privately Insured and for Those With Public-Private Insurance 2Health News:J.D. Power and Associates Reports: Among Pharmacy Customers, Satisfaction is Equally as High for the Privately Insured and for Those With Public-Private Insurance 3Health News:J.D. Power and Associates Reports: Among Pharmacy Customers, Satisfaction is Equally as High for the Privately Insured and for Those With Public-Private Insurance 4Health News:J.D. Power and Associates Reports: Among Pharmacy Customers, Satisfaction is Equally as High for the Privately Insured and for Those With Public-Private Insurance 5Health News:J.D. Power and Associates Reports: Among Pharmacy Customers, Satisfaction is Equally as High for the Privately Insured and for Those With Public-Private Insurance 6Health News:J.D. Power and Associates Reports: Among Pharmacy Customers, Satisfaction is Equally as High for the Privately Insured and for Those With Public-Private Insurance 7Health News:DynaVox Mayer-Johnson Receives Microsoft Award 2Health News:Study Finds Racial Inequalities Cost U.S. Health System Over $50 Billion a Year 2Health News:Study Finds Racial Inequalities Cost U.S. Health System Over $50 Billion a Year 3Health News:Study Finds Racial Inequalities Cost U.S. Health System Over $50 Billion a Year 4
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of innovative medical-related ... their most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the ... the most litigious industry sectors of cases involving ...
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... REDWOOD CITY, Calif., March 19, 2012 Ingenuity Systems, ... life science researchers, today announced that the Weill Cornell ... iReport for use in its sequencing core facility.  Variant ... the output of whole genome and exome sequencing experiments ...
... 19, 2012  Johnson & Johnson (NYSE: JNJ) will provide ... parties on Monday, March 26th at approximately 10:30 ... College of Cardiology (ACC) Annual Scientific Sessions in ... of the EINSTEIN-PE study in treating patients with ...
Cached Medicine Technology:Weill Cornell Medical College Selects Ingenuity® Variant Analysis™ and Ingenuity® iReport™ for Sequencing Core Facility 2
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint. Wavelength: 520 nm. Linearity: 1000 mg/dL (11.3 mmol/L). Single vial, dry powder reagent....
Alkaline phosphatase FS (IFCC). For determination of alkaline phosphatase (ALP) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
Intended for the quantitative determination of alkaline phosphatase activity in serum or plasma. Kinetic reaction. 405 nm wavelength. 830 U/L at 30C linearity. Single vial, dry powder reagent....
For the direct quantitative determination of low density lipoprotein cholesterol (LDL-C) in human serum or plasma. For in vitro diagnostic use only....
Medicine Products: